Educational Objectives
GENERAL INTERNAL MEDICINE - SEPTEMBER 10, 2011
Updates in General Internal Medicine
1. Recognize the difference between pathophysiologic outcomes versus disease process outcomes in clinical studies. 2. Review several of the latest controversies in Internal Medicine. 3. Foster a collegial discussion regarding appropriate patient care ( too much vs. too little)
New Drugs for Primary Care: What You Need to Know
1. Discuss which newly approved drugs have a potential role in primary care practice
2. Describe the comparative efficacy of new drugs compared to existing drugs. 3. Describe the important side effects of new drugs for primary care.
Application for Genetics and Genomics in Primary Care
1. Describe whole genome sequencing. 2. Describe how to evaluate family history 3. Discuss direct to consumer testing.
Injections for Back Pain
1. Understand what interventional pain is and how it fits into a treatment plan for chronic back pain. 2. Review spinal anatomy and sources of back pain. 3. Review indications and contraindications for injections of the spine, including steroid effects. 4. Learn about types of injections and their efficacy for back pain through case study
CARDIOVASCULAR MEDICINE - OCTOBER 15, 2011
Abdominal Aortic Aneurysms: Screening Recommendations and Endovascular vs. Surgical Treatment Options
1. Discuss the prevalence, risk factors for and natural history of abdominal aortic aneurysm (AAA). 2. Review the current screening recommendations, follow-up and imaging options for AAA. 3. Describe the basic patient selection criteria and timing of traditional open AAA repair and endovascular AAA repair (EVAR). 4. Discuss current trends and what the future holds for the treatment of AAA.
Diagnosis and Management of Peripheral Vascular Disease
1. Recognize a population at risk for peripheral arterial disease. 2. Describe the historical features and physical findings that suggest peripheral arterial disease. 3. Identify medical therapies that improve outcomes in peripheral arterial disease. 4. Describe the noninvasive work-up of patients with peripheral arterial disease.
Evaluation and Management of Atrial Fibrillation
1. Review the changing epidemiology and newly identified risk factors for atrial fibrillation. 2. List the advantages and limitations of anti-arrhythmic therapy for atrial fibrillation. 3. Discuss the advantages and limitations of ablation of atrial fibrillation.
Outpatient Management of Heart Failure: Keeping Patients Alive and Out of the Hospital
1. Differentiate systolic and diastolic heart failure. 2. Review the evidence-based therapies for heart failure. 3. Describe how to avoid medications which adversely affect heart failure and manage the side effects of medications used to treat heart failure.
ORTHOPEDICS - NOVEMBER 12, 2011
Current Advances in the Surgical Treatment of Hip and Knee Osteoarthritis
1. Discuss the indications for surgical intervention for hip and knee arthritis. 2. Discuss the recent advances that have been made in joint replacement surgery. 3. Describe the outcomes following total hip and knee replacement surgery
Common Orthopedic Emergencies
1. Discuss the diagnosis and management for open fractures, dislocations, compartment syndrome and septic joints.
Safe and Effective Opioid Prescribing for Chronic Pain
1. Discuss the breadth and quality of evidence for the use of opioids for chronic pain, including current gaps in knowledge. 2. Describe appropriate assessment, monitoring and documentation strategies to meet best practice standards and medico-legal requirements to support opioid prescribing.3. Apply a practical framework for decision-making on the initiation, maintenance, and discontinuation of opioid analgesics for the treatment of chronic pain.
A Rational Approach to Back Pain
1. Describe the clinical features of principal low back pain syndromes. 2. List the treatment options for the principal low back pain syndromes and the effectiveness of these treatments.
Traumatic Brain Injury: From Concussions to More Severe Injury
1. Describe how to identify concussion symptoms and post concussion syndrome. 2. Discuss the epidemiology of traumatic brain injury including mortality/morbidity statistics. 3. Describe chronic traumatic encephalopathy. 4. Review the complications of mismanagement of concussion. 5. Discuss past, present and future of concussion management. 6. Describe the pathophysiology of concussion.
NEUROLOGY - DECEMBER 10, 2011
Review of the Spectrum of Anxiety Disorders
1. Distinguish and differentiate between the different presentations of anxiety disorders. 2. Describe the link between anxiety and medical disorder. 3. Explain the underlying pathophysiology of anxiety disorders. 4. Design and implement treatment that can reduce the impact of anxiety disorder.
Multiple Sclerosis: Where are we with Oral Agents for Treatment?
1. Review the epidemiology and pathophysiology of MS. 2. List the common presenting signs and symptoms of MS. 3. Describe the diagnostic work up of patients with potential MS. 4. Discuss the clinical course of patients with MS. 5. List the established and emerging treatments for patients with MS.
Peripheral Neuropathy: A Case-Based Overview
1. Describe peripheral neuropathy signs and symptoms, and differential diagnosis. 2. Describe the common subtypes of peripheral neuropathy, including case examples, presentation of evaluation algorithm, including diagnostic tests. 3. Discuss the general management with focus on medication treatment options.
INFECTIOUS DISEASE - JANUARY 14, 2012
Treatment of Cellulitis and Soft Tissue Infections in Primary Care
1. Differentiation of soft tissue infections by depth, extent, and presence/absence of necrosis. 2. Review the selection of antibiotic therapy for S/ST infections. 3. Discuss the role of surgery in management of serious soft tissue infections.4. Describe the prevention of recurrent folliculitis/furunculosis and cellulitis.
Overview of Antibiotic Therapy for PCP’s
1. Apply the concepts of antibiotic stewardship to ambulatory practice 2. Review the appropriate oral antibiotics for common bacterial infections. 3. Recognize new sexy oral antibiotics and determine when they are appropriate. 4. Evaluate strategies for using parenteral antibiotics in the ambulatory setting
Update on Immunizations
1. Describe the available vaccines recommended for adolescents and adults, and their effective use. 2. Review the advantages of adult immunization in respect to personal and population health. 3. List applicable measures to improve adult immunization in primary care. 4. Describe public health initiatives to prevent influenza, pertussis, meningococcal disease and disease due to human papillomavirus infection.
STD Diagnosis, Treatment, and Screening
1. Describe the diagnosis and treatment of and screening for common sexually transmitted diseases using a case-based approach.
ENDOCRINOLOGY - FEBRUARY 11, 2012
The Vitamin D Debate: When to check for Vitamin D deficiency, and how aggressively to treat? What about calcium supplementation?
1. Describe the role of vitamin D in normal calcium and bone physiology. 2. List those at increased risk for vitamin D deficiency. 3. Describe how to incorporate the most recent Institute of Medicine and Endocrine Society guidelines into clinical practice.
Osteoporosis Screening and Therapy: Current Best Practice
1. Define major risk factors for osteoporosis and how to use these to guide treatment 2. List the current treatment modalities for established osteoporosis including: mechanism of action, adverse effects and selection of therapy. 3. Describe new approaches to treatment of osteoporosis including: when, how, and for how long.
Update in Diabetes Management
1. Discuss the origins of and risk factors for the type 2 diabetes epidemic. 2. Describe the pathophysiology of type 2 Diabetes especially as it relates to effective means of prevention and treatment
3. Discuss the clinical trials that have tested and established methods of prevention. 4. List the specific metabolic goals of therapy and their rationale. 5. Describe the available treatments for type 2 Diabetes, comparing and contrasting new and old medications and their efficacy in achieving target glycemia, their adverse effects, acceptability and costs.
HEMATOLOGY-ONCOLOGY – MARCH 10, 2012
How and When to Evaluate Patients for Thrombophilia
1. Describe the important acquired and hereditary thrombophilic conditions. 2. Discuss the pathophysiology of specific thrombophilic conditions. 3. Identify patients who should be tested for thrombophilia and list the appropriate tests.
How and When to Use Alternatives to Warfarin Therapy
1. Describe the pitfalls of warfarin therapy. 2. Identify new alternative anticoagulants to warfarin. 3. Discuss the pharmacokinetics of new anticoagulants. 4. Describe how to implement therapy for the appropriate indications. 5. Describe how to manage new anticoagulants.
Primary Prevention Strategies for Breast, Colon, and Prostate Cancer: What is the Evidence for Decreasing Risk with Medical Therapy?
1. Discuss the role of selective estrogen receptor modulators and aromatase inhibitors in the management of breast cancer. 2. Discuss the role of NSAIDS in the management of colon cancer. 3. Discuss the role of 5-alpha reductase inhibitor and metformin in the management of prostate cancer.
MGUS: Recognition, Monitoring Progression, and Stratifying Risk
1. Discuss the incidence of monoclonal gammopathy. 2. Define relation to other plasma cell dyscrasia. 3. Describe how to determine the frequency and type of follow-up for individuals with monoclonal gammopathy. 4. Review how to risk-stratify monoclonal gammopathy
PULMONARY MEDICINE - APRIL 14, 2012
Pulmonary Hypertension Update
1. Discuss the current classifications of pulmonary hypertension. 2. Discuss the current demographics of pulmonary hypertension 3. Discuss when to think of the disease and the basic evaluations. 4. List the current medications used to treat this disease.
Managing Patients with COPD
1. Define COPD, and it’s clinical presentation. 2. Describe the diagnosis, staging and prognosis in patients with COPD. 3. Discuss the role of various medical therapies in COPD. 4. Discuss the role of pulmonary rehab in management of chronic COPD. 5. List and describe the surgical options for COPD: indications and outcomes.
Treating Tobacco Use: How to Be Successful
1. Review current clinical guidelines for working with smokers in office practice. 2. Discuss new evidence-based ways to use pharmacotherapy for smoking cessation. 3. Provide a systems-level approach to building tobacco treatment into office practice.
Lung Cancer Screening: Where are We?
1. Summarize and identify pitfalls with previous lung cancer screening studies. 2. Review in detail recent National Lung Screening Trial results. 3. Describe the implications of lung cancer screening including risk/benefit ratio and cost effectiveness.
UROLOGY – MAY 12, 2012
Current Status of Therapies for Female Urinary Incontinence
1. Describe how to evaluate female urinary incontinence using history, exam and voiding diary. 2. Describe office treatment of female urinary incontinence. 3. List the most current treatment modalities, non-surgical and surgical, for female urinary incontinence.
What Causes Calcium Stones, and How are They Prevented?
1. Review the epidemiology of kidney stones, and risk factors for the most common cause of kidney stones (Calcium oxalate stones= 80%). 2. List the causes of hypercalciuria and hyperoxaluria. 3. Describe the diagnosis and management of acute kidney stones. 4. Review prognosis and follow up after a diagnosis of calcium oxalate stones.
Evaluation and Treatment of Male Sexual Dysfunction
1. Describe physiology/biochemistry/pathophysiology of erectile dysfunction. 2. Discuss current information concerning phosphodiesterase inhibitors. 3. List other erectile dysfunction treatment options
4. Describe the role of androgens in male sexual function/dysfunction
HPV Infection and Risk of Cancer in Males: Should We Be Vaccinating Men?
1. Review epidemiology of male HPV-associated disease, including genital warts and anogenital and oropharyngeal cancers. 2. Review HPV vaccine immunogenicity, efficacy for prevention of male HPV-associated disease, and vaccine-associated adverse events. 3. Discuss current male HPV vaccination guidelines and their rationale.
